& Jane Hoffman 2013 Descendants Michael is 10% at Onconova Therapeutics, Inc. (ONTX). They have made 4 open-market trades across 1 company since 2013, most recently 2014-02-21.
CIK 0001581996
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $17.3M since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ONTX | 4,518,275 | $41.8M |
Shares reported on the most recent Form 4, priced at the 2014-02-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONTX | BUY | 2014-02-20 | 2014-02-24 | $8.47 | $1.2M | -26.3% | -3.2% | -3.2% |
| ONTX | BUY | 2014-01-24 | 2014-01-27 | $11.92 | $683K | -26.3% | -3.2% | -3.2% |
| ONTX | BUY | 2013-11-22 | 2013-11-25 | $14.39 | $72K | -26.3% | -3.2% | -3.2% |
| ONTX | BUY | 2013-11-18 | 2013-11-20 | $11.87 | $59K | -26.3% | -3.2% | -3.2% |
| ONTX | BUY | 2013-11-15 | 2013-11-18 | $11.99 | $236K | -26.3% | -3.2% | -3.2% |
| ONTX | BUY | 2013-07-30 | 2013-08-01 | $15.00 | $15.0M | -26.3% | -3.2% | -3.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.